Interestingly, changes in the CD4+ Tconv subset within the tumor were far less discriminative than those in the tdLN, likely reflective of the known predominant role of CD8+ T cells in mediating antitumor immunity and corresponding immunotherapy resistance upon sucralose treatment (Supplementary Fig. S5K–S5N). The gene discussed is CD4; the disease is neoplasm.